SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Cost cutting, budget slashing, financial control. Trendy halftone collage. Concept of cost cutting, expense management, and business strategy. Vector illustration
Earnings
Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth
Eli Lilly’s $19.8 billion revenue for the first quarter could have been higher if not for declining prices for key medicines like Zepbound, Mounjaro and Taltz.
April 30, 2026
 · 
2 min read
 · 
Annalee Armstrong
Alarm clock with pause sign, take a break, menopause concept, hormone replacement therapy
Schizophrenia
Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study
The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia drug.
April 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Pruning tree branches. Gloved hands hold a branch and cutting shears, the gardener takes care of the park. Vector illustration.
Pipeline
AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolio
While AstraZeneca has discontinued work on four assets—including one in asthma and another in acromegaly—the pharma has also elected to take forward a bispecific antibody that destroys the EGFR protein.
April 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Conceptual business illustration of upcoming business problem metaphor with falling domino and businessman silhouette. Minimalistic vector eps 10 illustration
Alzheimer’s disease
GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints
Over the last two years, Alector has suffered three setbacks for its neurodegenerative disease pipeline, often forcing the company to downsize.
April 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Business threat, fight to survive in business competition, resilience or adversity, challenge or survive to win, courage fighter concept, businessman hold shield to fight with multiple fighter punch.
Weight loss
Lilly CEO shades amylin rivals AbbVie, Pfizer in cutthroat battle for obesity’s next act
Amylin drugs have become the next big thing in obesity. Eli Lilly CEO David Ricks, understandably, thinks his rivals don’t have a chance for one key reason.
April 30, 2026
 · 
2 min read
 · 
Annalee Armstrong
Insights
What makes life science angel investment work?
In this episode of Denatured, you’ll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a life sciences-only angel group matters, how they evaluate opportunities, and the importance of strong teams, capital efficiency and a realistic path to exit.
April 30, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Business concept illustration of a businessman sitting contemplating on fallen arrow sign, bankruptcy, failure in business concept
Company closure
6 biotechs that called it quits in Q1
Six biotechs based in California, Massachusetts, Washington and Denmark had to halt drug development efforts this year. One of their CEOs is now in an interim chief executive role at another biotech.
April 30, 2026
 · 
6 min read
 · 
Angela Gabriel
Photo of Durham, North Carolina, USA downtown cityscape
Job Trends
7 companies hiring in North Carolina now
Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences professionals like you.
April 30, 2026
 · 
1 min read
 · 
Angela Gabriel
Determined man pushing several stones at once\
Job Trends
Show, don’t tell: doing free work during the interview process
Over one-third of BioSpace LinkedIn poll respondents have done free work while interviewing for jobs. A recruiting expert and career coach discuss why employers make work requests and how biopharma professionals should evaluate and respond to them.
April 30, 2026
 · 
6 min read
 · 
Angela Gabriel
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS